Patients should understand that while the medication itself won't show up on blood tests, the therapeutic effects of GLP-1 drugs are clearly evident through improved metabolic markers: lower HbA1c, reduced fasting glucose, potential improvements in lipid profiles, and weight loss
By altering how these hormones function, retatrutide can help reduce blood sugar and increase fat metabolism
Rarely, and it is generally unsafe without close monitoring
When you begin a semaglutide-based weight loss program at our practice, our team of experienced providers will start you on a low dose, gradually increasing it over several weeks to reduce the risk of side effects
Second cardiovascular safety trial to demonstrate that a GLP-1R agonist reduces MACE and microvascular (including renal) events in patients with T2DM and high cardiovascular risk